Structura Biotechnology is a pioneering brand that specializes in harnessing the power of cryo-electron microscopy (cryo-EM) for life sciences and drug discovery. As a Nobel Prize-winning technique, cryo-EM allows for high-throughput structure determination of proteins and other biological molecules in their near-native states. Structura Biotechnology's flagship product, CryoSPARC, is a state-of-the-art platform used globally for cryo-EM data analysis and 3D reconstruction.

With specially designed algorithms, CryoSPARC offers advanced solutions for membrane proteins, ion channels, GPCRs, and drug targets. Since its founding in 2016, Structura Biotechnology has achieved significant milestones in the field of cryo-EM. Their software has been adopted by over 600 institutions across 40+ countries and has received over 2,800 citations.

In collaboration with Thermo Fisher Scientific, Structura Biotechnology is integrating their cutting-edge software with cryo-EM microscopes for real-time data analysis. The brand's commitment to innovation is evident with the release of CryoSPARC v3, which introduced numerous improvements to the cryo-EM data processing workflow, including methods for modeling continuous heterogeneity. With a talented team and a focus on advancing cryo-EM technology, Structura Biotechnology is at the forefront of revolutionizing structural biology and drug discovery